注册试验中定性方法报告情况及产出探索(EQUITY):系统综述
该研究检索了1999年至2016年ClinicalTrials.gov、ISRCTN和WHO ICTRP三个注册库,共纳入615,311项试验,确认其中1492项(0.24%)使用了定性方法。使用定性方法的试验数量随时间增加,且多来自高收入国家,主要评估行为或其他干预,而药物、器械和手术试验中较少。
要点
- 注册试验中报告使用定性方法的比例极低,仅0.24%。
- 定性方法的使用随时间增加,但主要集中在高收入国家和行为干预试验。
- 手术、器械和药物试验以及低收入国家试验中定性方法应用不足。
核心结论
- 注册试验中报告使用定性方法的比例随时间增加,但总体仍很低,且分布不均。
研究设计与样本
- 系统综述,检索三个试验注册库(ClinicalTrials.gov、ISRCTN、WHO ICTRP)从1999年至2016年的记录,共615,311项试验。
主要发现
- 共确认1492项(0.24%)注册试验报告使用定性方法。
- ISRCTN中报告使用定性方法的比例最高(3.4%),ClinicalTrials.gov为0.3%,WHO ICTRP为0.03%。
- 报告使用定性方法的试验数量从1999年的0项(0.0%)增至2016年的285项(0.38%)。
- 这些试验来自52个国家,其中38%在英国,28%在美国。
- 多数试验评估行为干预(39%)或其他干预,药物(5%)、医疗器械(5%)和手术干预(4%)较少。
临床怎么用
- 应鼓励在手术、器械和药物试验以及低收入国家开展的试验中使用定性方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The value of qualitative methods within trials is widely recognised, but their full potential is not being realised. There are also issues with the visibility, recognition and reporting of qualitative methods in trials. To identify potential improvements in qualitative research within trials, we need to study trials that have included qualitative methods. We aimed to explore the frequency of reporting qualitative methods in registered trials, the types of trials using qualitative methods and where in the world these trials were conducted. METHODS: We included registries if they were searchable using keywords and held summaries of trials rather than listing reports or publications. We searched the included registries from the first available record in 1999 to the end of 2016 for the term 'qualitative'. We included trials only if we could confirm that they used qualitative methods through documented use of qualitative data collection and analysis in the registry summary. We analysed registered trials reporting the use of qualitative methods by: year registered, the country responsible for overseeing governance of the trial and the type of trial intervention (categorised as surgical, medical device, behavioural, drug or other). RESULTS: We included three registries: ClinicalTrials.gov, the International Standard Randomised Controlled Trial Number Registry (ISRCTN) and the World Health Organisation International Clinical Trials Registry Platform (WHO ICTRP). A total of 615,311 trials appear in these three registries from 1999 until the end of 2016. Numbers differed across registries with the WHO ICTRP the largest (366,753 trials), ClinicalTrials.gov the second largest (233,277) and ISRCTN the smallest (15,301). Of these registered trials, we confirmed that 1492 (0.24%) reported using qualitative methods. The ISRCTN contributed the highest percentage of trials reported as using qualitative methods (3.4%); in contrast, ClinicalTrials.gov reported 0.3% and WHO ICTRP reported 0.03%. The number and percentage of trials reported to use qualitative methods increased over time from 0 (0.0%) in 1999 to 285 (0.38%) in 2016. Trials reported as using qualitative methods originated from 52 countries across the world. Most were in Western higher-income countries: 38% in the United Kingdom and 28% in the United States. Most registered trials reported as using qualitative methods evaluated behavioural (39%) or other interventions with many fewer trials evaluating drugs (5%), medical devices (5%) or surgical interventions (4%). CONCLUSION: The reported use of qualitative methods in registered trials has increased over time and worldwide. They are reportedly more frequent in high-income countries and in trials of behavioural and other interventions. Trialists and other stakeholders need to recognise the benefits of using qualitative methods in surgical, device and drug trials, and trials conducted in poorer countries. Moreover, they should seriously consider using qualitative methods in these trials.
引用
- Clement C, Edwards SL, Rapport F, et al. Exploring qualitative methods reported in registered trials and their yields (EQUITY): systematic review. Trials. 2018. PMID: 30373646. doi:10.1186/s13063-018-2983-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。